Plus   Neg

QSC Q3 Revenues Rise Sequentially; Sees Revenue Growth In Q4 - Quick Facts

German Cloud and ICT provider QSC AG (QSCGF) reported Tuesday that its third-quarter revenues were 32.3 million euros, following the sale of its telecommunications subsidiary Plusnet.

Sequentially, revenues grew 7 percent from 30.1 million euros recorded in the second quarter, excluding Plusnet.

The Cloud business, with its two areas of Cloud Services and Internet of Things or IoT, posted third-quarter revenues of 10.2 million euros, 24 percent higher than in the previous quarter.

Consulting revenues grew 4 percent to 10.5 million euros. At 7.0 million euros, Outsourcing revenues were in line with expectations, as were the Colocation revenues of 4.6 million euros.

Looking ahead, CEO Jürgen Hermann said, "QSC is now a growth company once again. And we have budgeted revenue growth for the current fourth quarter as well."

This will be aided by ongoing high volumes of new orders.

QSC will publish its third quarter results on November 11.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. (AAPL) unveiled a 16-inch MacBook Pro laptop with a larger screen and redesigned keyboard. It is the first major update since the MacBook Pro line was revamped three years ago. The company has moved from a 15-inch screen to a higher-resolution 16-inch screen. Facebook has launched its new payment platform called 'Facebook Pay' in the U.S., joining other tech giants like Google and Apple that have their own payment platforms. The new service will be available across Facebook and its associated apps - Messenger, Instagram and WhatsApp, the social media giant said in a blog post. The payment service supports most major credit and debit cards. Amneal Pharmaceuticals, LLC recalled certain lots of heartburn medication Ranitidine in the form of tablets and syrup for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine, above levels established by the U.S. Food and Drug Administration or FDA. The generic and specialty pharma company is recalling 94 lots of Ranitidine tablets and Syrup.
Follow RTT